Freddy Flores Ferreras
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 152 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 20.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,169, 5.3 times the $408 reported in 2022. Among family clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 152 payments — averaging $26.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$852
- AbbVie$731
- Novo Nordisk$585
- Lilly USA, LLC$377
- Astellas Pharma US Inc$225
- Boehringer Ingelheim$223
- plus $1K from 19 others
What the payments were for
- Food & beverage$4,093100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 21 | $852 |
| AbbVie | 28 | $731 |
| Novo Nordisk | 24 | $585 |
| Lilly USA, LLC | 24 | $377 |
| Astellas Pharma US Inc | 12 | $225 |
| Boehringer Ingelheim | 6 | $223 |
| UCB, Inc. | 2 | $160 |
| TG Therapeutics, Inc. | 1 | $125 |
| SK Life Science, Inc. | 1 | $111 |
| Phathom Pharmaceuticals, Inc. | 6 | $88 |
| Bayer | 3 | $74 |
| Smith+Nephew | 1 | $71 |
| Pfizer | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 4 | $63 |
| Amgen | 3 | $58 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Lundbeck LLC | 2 | $40 |
| Verona Pharma, Inc. | 1 | $37 |
| Abbott | 2 | $37 |
| Johnson & Johnson | 1 | $26 |
| Kyowa Kirin, Inc. | 1 | $24 |
| Biosense Webster, Inc. | 1 | $19 |
| GSK | 1 | $18 |
| Acadia Pharmaceuticals Inc | 1 | $17 |
| Insmed, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,093 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 48 | $1,262 |
| Atorvastatin Calcium | 57 | $610 |
| Omeprazole | 36 | $431 |
| Rosuvastatin Calcium | 24 | $233 |
| Pantoprazole Sodium | 26 | $227 |
| Losartan Potassium | 29 | $179 |
| Gabapentin | 19 | $174 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 14 | $171 |
| Amlodipine Besylate | 28 | $156 |
| Levothyroxine Sodium | 26 | $155 |
| Metformin Hcl | 11 | $102 |
| Azithromycin | 21 | $87 |
| Fluticasone Propionate | 16 | $84 |
| Lisinopril | 14 | $77 |
| Methylprednisolone | 11 | $65 |
Paid to pharmacies, not to this prescriber.
Other family in Tampa
- Lewis HarringtonTampa$954K
- Marie Labadie-DegennaroTampa$66K
- Polly BittleTampa$63K
- Katharine WilliamsTampa$47K
- Candace DeberryTampa$46K
- Bailey BlankenshipTampa$42K
- Rasheeta ChandlerTampa$37K
- Rosaly TorresTampa$28K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.